Published in Cancer Res on January 12, 2010
Antitumor effects of somatostatin analogs in neuroendocrine tumors. Oncologist (2012) 1.17
The PI3K/Akt Pathway in Tumors of Endocrine Tissues. Front Endocrinol (Lausanne) (2016) 0.85
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary (2016) 0.83
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice. Invest New Drugs (2011) 0.82
Peptide receptor targeting in cancer: the somatostatin paradigm. Int J Pept (2013) 0.77
Treatment of pituitary carcinomas and atypical pituitary adenomas: a review. Neurol Med Chir (Tokyo) (2014) 0.77
Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategy. Am J Transl Res (2014) 0.76
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro. Oncotarget (2017) 0.75
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest (2003) 3.62
The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12
The trigemino-cardiac reflex: an update of the current knowledge. J Neurosurg Anesthesiol (2009) 2.59
RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell (2007) 2.34
Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res (2003) 2.11
Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain (2013) 1.95
Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab (2006) 1.87
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism (2010) 1.81
Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab (2005) 1.79
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol (2005) 1.70
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol (2011) 1.69
Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med (2008) 1.66
Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol (2010) 1.65
Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology (2006) 1.57
Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery (2007) 1.52
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol (2002) 1.47
On the quest for a biomechanism of transsexualism: is there a role for BDNF? J Psychiatr Res (2013) 1.47
Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol (2007) 1.45
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet (2006) 1.42
Follow-up and long-term outcome of nonfunctioning pituitary adenoma operated by transsphenoidal surgery with intraoperative high-field magnetic resonance imaging. Acta Neurochir (Wien) (2014) 1.41
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. Cell Cycle (2012) 1.41
Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res (2005) 1.40
Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults. Pharmacogenomics (2008) 1.39
Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol (2011) 1.37
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res (2006) 1.37
Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling. J Biol Chem (2007) 1.31
Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol (2013) 1.31
Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem (2009) 1.28
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology (2006) 1.27
Somatostatin receptors: from signaling to clinical practice. Front Neuroendocrinol (2013) 1.25
Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol (2006) 1.25
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab (2010) 1.24
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. Cancer Res (2006) 1.24
Piezoelectric bone surgery: a revolutionary technique for minimally invasive surgery in cranial base and spinal surgery? Technical note. Neurosurgery (2005) 1.24
Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab (2012) 1.24
Prediction of visual field deficits by diffusion tensor imaging in temporal lobe epilepsy surgery. Neuroimage (2008) 1.24
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res (2010) 1.24
17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol (2007) 1.23
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol (2009) 1.19
Towards a clinico-pathological classification of granule cell dispersion in human mesial temporal lobe epilepsies. Acta Neuropathol (2009) 1.17
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin Cancer Res (2008) 1.16
Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery (2005) 1.16
Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structures. Neuroimage (2006) 1.15
Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg (2008) 1.12
Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol (2011) 1.11
Improving the extent of malignant glioma resection by dual intraoperative visualization approach. PLoS One (2012) 1.10
Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res (2006) 1.10
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg (2011) 1.10
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene (2005) 1.08
An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J (2010) 1.08
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis (2010) 1.07
Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol (2009) 1.07
Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans. Brain (2010) 1.07
Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int (2006) 1.06
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol (2004) 1.06
Measuring abdominal obesity: effects of height on distribution of cardiometabolic risk factors risk using waist circumference and waist-to-height ratio. Diabetes Care (2011) 1.06
c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS One (2009) 1.06
The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res (2007) 1.05
Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl) (2008) 1.04
Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci (2009) 1.04
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor. Neuro Oncol (2009) 1.04
History of the cushing reflex. Neurosurgery (2006) 1.03
Tumor volume of growth hormone-secreting pituitary adenomas during treatment with pegvisomant: a prospective multicenter study. J Clin Endocrinol Metab (2009) 1.03
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr Relat Cancer (2009) 1.03
NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion. Biochim Biophys Acta (2012) 1.02
Lobar localization information in epilepsy patients: MEG--a useful tool in routine presurgical diagnosis. Epilepsy Res (2007) 1.02
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res (2008) 1.01
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol (2006) 1.01
Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc Natl Acad Sci U S A (2005) 1.01
The sitting position in neurosurgery: indications, complications and results. a single institution experience of 600 cases. Acta Neurochir (Wien) (2013) 1.00
Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol (2005) 1.00
PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters. Mol Pharmacol (2004) 1.00
CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation. Ann N Y Acad Sci (2006) 0.99
Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett (2003) 0.99
In silico structural and functional characterization of the RSUME splice variants. PLoS One (2013) 0.99
Molecular imaging of brain tumors personal experience and review of the literature. Curr Mol Med (2008) 0.99
Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol (2010) 0.98
Chemokines and chemokine receptors: new actors in neuroendocrine regulations. Front Neuroendocrinol (2010) 0.98
Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation. Transl Oncol (2008) 0.98
Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci (2002) 0.97
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica (2011) 0.97
Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology (2006) 0.97
Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature. Neurosurg Focus (2014) 0.97
Diffusion tensor-based fiber tracking and intraoperative neuronavigation for the resection of a brainstem cavernous angioma. Surg Neurol (2007) 0.96
Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas. J Clin Endocrinol Metab (2008) 0.96
Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer (2006) 0.96
Molecular transduction mechanisms of cytokine-hormone interactions: role of gp130 cytokines. Exp Physiol (2007) 0.96
Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus. J Virol (2004) 0.96
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Toxicology (2013) 0.96
Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results. Invest Radiol (2007) 0.95
Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95
Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice. J Neuroimmunol (2006) 0.95
Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids. Int J Biochem Cell Biol (2012) 0.95
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures. Cell Cycle (2013) 0.95